You are here: Industry Insights > patients

News List

Researchers warn about gangrene cases in patients on SGLT2 diabetes drugs fiercepharma
May 12, 2019
After the FDA last year slapped a warning label on SGLT2 diabetes drugs, detailing risks of an infection with a rare flesh-eating bacteria, a team of researchers has come out with a new set of numbers—and a warning for doctors prescribing the drugs.
Bristol-Myers Squibb's Opdivo fails to hit survival goal in study of patients with newly diagnosed MGMT-unmethylated glioblastoma multiforme firstwordpharma
May 10, 2019
Bristol-Myers Squibb said Thursday that a Phase III study evaluating Opdivo (nivolumab) plus radiation versus temozolomide plus radiation in patients with newly diagnosed MGMT-unmethylated glioblastoma multiforme (GBM) failed to ...
Significant Number of Referred Patients Misdiagnosed With MS drugs
April 28, 2019
Nearly one in five patients referred to a multiple sclerosis specialty center are misdiagnosed, according to a study published in the May issue of Multiple Sclerosis and Related Disorders.
Statins Safe, Effective in Rheumatoid Arthritis Patients drugs
April 22, 2019
Statins Safe, Effective in Rheumatoid Arthritis Patients
‘Half a million’ GP hours freed for patients pharmatimes
April 16, 2019
NHS England has announced that its Time for Care programme has freed up more than half a million hours of time for patients in the last year.
Lonza, Chr. Hansen Set Up Microbiome JV pharmatimes
April 04, 2019
Headquarters and pharma-grade drug production facility to be established in Switzerland.
Triphase Accelerator Initiates Phase I Trial of TRPH-222 contractpharma
April 02, 2019
Next-Gen Antibody-Drug Conjugate developed using Catalent’s SMARTag ADC Technology
Schreiner MediPharm Label Supports YpsoMate Autoinjector contractpharma
March 28, 2019
Stored information about the medication is transmitted to its electronic add-on and is recorded via the autoinjector and logged by the SmartPilot
HitGen & Almirall Enter Research Collaboration contractpharma
March 27, 2019
HitGen will apply its advanced technology platform, based on DNA-encoded library design, synthesis and screening, to discover novel leads for Almirall.
CRO Inks OmniComm EDC Agreement contractpharma
March 19, 2019
Will use TrialMaster for future studies, including an upcoming Phase Ib study on behalf of a sponsor based in the UK.

Previous page 1 2 3 4 5 6 7 8 Next page